Nothing to Sneeze At! Global Pharma-Bio Sector Wraps Up $4.74 Billion in Construction Projects in 2Q17
Nothing to Sneeze At! Global Pharma-Bio Sector Wraps Up $4.74 Billion in Construction Projects in 2Q17
Attachment: Pharma-Biotech Completions 2Q17
SUGAR LAND--June 14, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--At the end of the second quarter of 2017, the global Pharmaceutical & Biotech Industry will have wrapped up construction on nearly $5 billion worth of reported capital and maintenance investments. Spread over 242 individual projects, construction should be complete between April 1 and June 30.
Within this article: Details on some of the major project completions from the second quarter, including those from top companies such as CSL Behring LLC, Takeda Pharma Vertrieb GmbH & Company and Elanco Animal Health.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Drug Money! North American Life Science Sector Wraps Up $16 Billion in Proj...
- Great Lakes Region Floats into 2015 with Nearly $500 Million in Life-Scienc...
- South Carolina Sees $7.7 Billion in Industrial Projects Under Construction
- Suffolk Construction Has Hand in $1.8 Billion Worth of U.S. Projects, Mostl...
- Alabama Sees $11.7 Billion in Projects Under Construction